Piñero D J, Hu J, Connor J R
Department of Neuroscience and Anatomy, Penn State University College of Medicine, M.S. Hershey Medical Center, PA 17033, USA.
Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):761-76.
Iron regulatory proteins (IRPs) are cytoplasmic mRNA binding proteins involved in intracellular regulation of iron homeostasis. IRPs regulate expression of ferritin and transferrin receptor at the mRNA level by interacting with a conserved RNA structure termed the iron-responsive element (IRE). This concordant regulation of transferrin receptors and ferritin is designed so a cell can obtain iron when it is needed, and sequester iron when it is in excess. However, we have reported that iron accumulates in the brain in Alzheimer's disease without a concomitant increase in ferritin. An increase in iron without proper sequestration can increase the vulnerability of cells to oxidative stress. Oxidative stress is a component of many neurological diseases including Alzheimer's. We hypothesized that alterations in the IRP/IRE interaction could be the site at which iron mismanagement occurs in the Alzheimer's brains. In this report we demonstrate that in normal human brain extracts, the IRP is detected as a double IRE/IRP complex by RNA band shift assay, but in 2 of 6 Alzheimer's brain (AD) extracts examined a single IRE/IRP complex was obtained. Furthermore, the mobility of the single IRE/IRP complex in Alzheimer's brain extracts is decreased relative to the double IRE/IRP complex. Western blot and RNA band super shift assay demonstrate that IRP1 is involved in the formation of the single IRE/IRP complex. In vitro analyses suggest that the stability of the doublet complex and single AD complex are different. The single complex from the AD brain are more stable. A more stable IRE/IRP complex in the AD brain could increase stability of the transferrin receptor mRNA and inhibit ferritin synthesis. At the cellular level, the outcome of this alteration in the molecular regulatory mechanism would be increased iron accumulation without an increase in ferritin; identical to the observation we reported in AD brains. The appearance of the single IRE/IRP complex in Alzheimer's brain extracts is associated with relatively high endogenous ribonuclease activity. We propose that elevated RNase activity is one mechanism by which the iron regulatory system becomes dysfunctional.
铁调节蛋白(IRPs)是细胞质mRNA结合蛋白,参与细胞内铁稳态的调节。IRPs通过与一种称为铁反应元件(IRE)的保守RNA结构相互作用,在mRNA水平上调节铁蛋白和转铁蛋白受体的表达。转铁蛋白受体和铁蛋白的这种协同调节机制是为了使细胞在需要时能够获取铁,并在铁过量时将其储存起来。然而,我们曾报道,在阿尔茨海默病患者的大脑中,铁会蓄积,而铁蛋白却没有相应增加。铁在没有适当储存的情况下增加,会增加细胞对氧化应激的易感性。氧化应激是包括阿尔茨海默病在内的许多神经疾病的一个组成部分。我们推测,IRP/IRE相互作用的改变可能是阿尔茨海默病大脑中铁管理不当的发生位点。在本报告中,我们证明,在正常人脑提取物中,通过RNA凝胶迁移试验可检测到IRP为双IRE/IRP复合物,但在检测的6份阿尔茨海默病(AD)脑提取物中有2份得到的是单IRE/IRP复合物。此外,与双IRE/IRP复合物相比,阿尔茨海默病脑提取物中单IRE/IRP复合物的迁移率降低。蛋白质免疫印迹和RNA凝胶迁移超迁移试验表明,IRP1参与了单IRE/IRP复合物的形成。体外分析表明,双峰复合物和单一AD复合物的稳定性不同。来自AD脑的单一复合物更稳定。AD脑中更稳定的IRE/IRP复合物可能会增加转铁蛋白受体mRNA的稳定性并抑制铁蛋白的合成。在细胞水平上,这种分子调节机制的改变结果将是铁蓄积增加而铁蛋白不增加,这与我们在AD脑中观察到的情况一致。阿尔茨海默病脑提取物中单IRE/IRP复合物的出现与相对较高的内源性核糖核酸酶活性有关。我们认为,核糖核酸酶活性升高是铁调节系统功能失调的一种机制。